Lung GvHD - Review of current practices Study type Diseases Group Transplant Complications Working Party (TCWP) Principal investigator John Murray; Saskia Bos
EBMT patient engagement taskforce (PRO) Diseases Group Transplant Complications Working Party (TCWP) Type of Stem Cell Treatment Principal investigator Helene Schoemans
Treatment Related and population mortality for Older Patients (TROP) Diseases Group Transplant Complications Working Party (TCWP) Principal investigator Johannes Schetelig; Liesbeth de Wreede
Outcomes and risk factors for survival of lung transplantation after allogeneic HSCT Diseases Group Transplant Complications Working Party (TCWP) Principal investigator Juan Montoro Gomez; Saskia Bos
Management of passage from pediatric to adult age (transiting) in pediatric EBMT centers Diseases Group Transplant Complications Working Party (TCWP) Type of Stem Cell Treatment Principal investigator Maura Faraci; Claire Horgan
Graft-versus-Host Disease after donor-derived chimeric antigen receptor T-cell infusion post allogeneic HSCT Diseases Group Transplant Complications Working Party (TCWP) Cellular Therapy & Immunobiology Working Party (CTIWP) Type of Stem Cell Treatment Principal investigator Guillermo Ortí
Secondary autoimmune and inflammatory diseases (sec.AIID) post allogeneic HSCT Diseases Group Transplant Complications Working Party (TCWP) Autoimmune Diseases Working Party (ADWP) Principal investigator Arsene Mekinian
Association of pre-existing co-morbidities with CAR-T therapy outcome - a retrospective analysis Diseases Group Transplant Complications Working Party (TCWP) Principal investigator Grzegorz Basak
Graft rejection in haploidentical HSCT: survey of subsequent therapeutic options Diseases Group Transplant Complications Working Party (TCWP) Principal investigator Nadira Durakovic
The impact of blood group disparities on the outcomes of allogeneic stem cell transplantation in the modern era Diseases Group Transplant Complications Working Party (TCWP) Principal investigator Michal Gorka
Complications after CD19 CAR T-Cell therapy: a retrospective study from the EBMT Transplant Complications Working Party Diseases Group Transplant Complications Working Party (TCWP) Principal investigator Olaf Penack
Bone marrow aplasia after CD19 CAR T-Cell therapy: a retrospective study from the EBMT Transplant Complications Working Party Diseases Group Transplant Complications Working Party (TCWP) Principal investigator Olaf Penack